BYBEE CLINTON
Insider CIK 1219043 · PI Director, 10% owner · XCOM Director, 10% owner · BLUE 10% owner · AKAO 10% owner · IOTS 10% owner · PZRX 10% owner · FATE 10% owner · KYTH 10% owner · AGIO 10% owner · UBX 10% owner · RCPT 10% owner · QTRX 10% owner · MASS 10% owner · SYRS 10% owner · PULM 10% owner · TWST 10% owner · JUNO 10% owner · SAGE 10% owner · BLPH 10% owner · MTCR 10% owner · SNNA 10% owner · CDAK 10% owner · FIXX 10% owner · VIR 10% owner · DNLI 10% owner · SRRK 10% owner · GOSS 10% owner · BEAM 10% owner · SANA 10% owner · KRTX 10% owner · BOLD 10% owner · LYEL 10% owner · NMRA 10% owner · VBIV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BOLD Boundless Bio, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 16,000 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 16,000 | $2.49 | $39.8K | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 16,000 | $1.03 | $16.5K | 16,000 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | P Buy | 2026-03-06 | 2026-03-09 | 488,090 | $25.61 | $12.50M | 1,426,528 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2025-10-27 | 2025-10-29 | 1,915,700 | $2.61 | $5.00M | 6,046,907 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 363,637 | $5.50 | $2.00M | 10,667,387 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 1,176,593 | — | $0 | 2,321,566 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 703,061 | — | $0 | 1,387,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-20 | 1,500,000 | $17.00 | $25.50M | 3,624,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 684,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 1,144,973 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 12,205,379 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 2,124,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 11,886,758 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-13 | 2022-09-15 | 5,000,000 | $1.50 | $7.50M | 8,854,098 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 239,559 | — | $0 | 5,626,008 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 310,441 | — | $0 | 7,290,655 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 14,383 | — | $0 | 272,964 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 1,624 | — | $0 | 30,570 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-06 | 2022-09-07 | 3,248 | — | $0 | 61,160 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 196,003 | — | $0 | 5,865,567 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 253,997 | — | $0 | 7,601,096 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 11,763 | — | $0 | 258,581 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 1,338 | — | $0 | 28,946 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-09-02 | 2022-09-07 | 2,662 | — | $0 | 57,912 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 1,475 | — | $0 | 27,608 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 13,076 | — | $0 | 246,818 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 282,219 | — | $0 | 7,855,093 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 217,781 | — | $0 | 6,061,570 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-31 | 2022-09-01 | 2,952 | — | $0 | 55,250 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 2,952 | — | $0 | 52,298 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 1,475 | — | $0 | 26,133 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 13,076 | — | $0 | 233,742 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 282,219 | — | $0 | 8,137,312 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-30 | 2022-09-01 | 217,781 | — | $0 | 6,279,351 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 217,781 | — | $0 | 6,497,132 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 2,952 | — | $0 | 49,346 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 1,475 | — | $0 | 24,658 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 13,076 | — | $0 | 220,666 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-25 | 2022-08-26 | 282,219 | — | $0 | 8,419,531 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 217,781 | — | $0 | 6,714,913 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 2,952 | — | $0 | 46,394 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 1,475 | — | $0 | 23,183 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 13,076 | — | $0 | 207,590 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-24 | 2022-08-26 | 282,219 | — | $0 | 8,701,750 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 1,475 | — | $0 | 21,708 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 217,781 | — | $0 | 6,932,694 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 282,219 | — | $0 | 8,983,969 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 2,952 | — | $0 | 43,442 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-18 | 2022-08-22 | 13,076 | — | $0 | 194,514 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 2,952 | — | $0 | 40,490 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 217,781 | — | $0 | 7,150,475 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 282,219 | — | $0 | 9,266,188 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 13,076 | — | $0 | 181,438 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-16 | 2022-08-16 | 1,475 | — | $0 | 20,233 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 217,781 | — | $0 | 7,368,256 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 282,219 | — | $0 | 9,548,407 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 13,076 | — | $0 | 168,362 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 1,475 | — | $0 | 18,758 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-15 | 2022-08-16 | 2,952 | — | $0 | 37,538 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 13,076 | — | $0 | 155,286 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 217,781 | — | $0 | 7,586,037 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 1,475 | — | $0 | 17,283 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 2,952 | — | $0 | 34,586 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-08-12 | 2022-08-16 | 282,219 | — | $0 | 9,830,626 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 217,781 | — | $0 | 7,803,818 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 2,952 | — | $0 | 31,634 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 282,219 | — | $0 | 10,112,845 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 1,475 | — | $0 | 15,808 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-08 | 2022-06-10 | 13,076 | — | $0 | 142,210 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 4,426 | — | $0 | 43,015 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 13,076 | — | $0 | 129,134 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 282,219 | — | $0 | 10,395,064 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2022-06-02 | 2022-06-06 | 217,781 | — | $0 | 8,021,599 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 987,767 | — | $0 | 10,677,283 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 45,703 | — | $0 | 116,058 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 762,233 | — | $0 | 8,239,380 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-12-20 | 2021-12-22 | 15,504 | — | $0 | 38,589 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 282,219 | — | $0 | 11,665,050 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 13,057 | — | $0 | 70,355 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 4,428 | — | $0 | 23,085 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-29 | 2021-12-01 | 217,781 | — | $0 | 9,001,613 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 217,781 | — | $0 | 9,219,394 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 4,428 | — | $0 | 18,657 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 282,219 | — | $0 | 11,947,269 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-11-22 | 2021-11-24 | 13,057 | — | $0 | 57,298 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 25,279 | — | $0 | 44,241 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 1,742,248 | — | $0 | 9,437,175 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 2,257,752 | — | $0 | 12,229,488 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-07-01 | 2021-07-06 | 8,133 | — | $0 | 14,229 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 200,000 | — | $0 | 2,921,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 200,000 | — | $0 | 2,921,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 4,686 | — | $0 | 28,111 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 811 | — | $0 | 4,867 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 2,555 | — | $0 | 15,328 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 200,000 | — | $0 | 3,121,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 2,555 | — | $0 | 12,773 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 4,686 | — | $0 | 23,425 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 200,000 | — | $0 | 3,121,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 811 | — | $0 | 4,056 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 4,686 | — | $0 | 18,739 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 811 | — | $0 | 3,245 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 2,555 | — | $0 | 10,218 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 200,000 | — | $0 | 3,321,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 200,000 | — | $0 | 3,321,519 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 6,320 | — | $0 | 18,962 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 564,438 | — | $0 | 14,487,240 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 2,028 | — | $0 | 6,096 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-06-22 | 2021-06-24 | 435,562 | — | $0 | 11,179,423 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 435,142 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 435,142 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 17,771,216 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 17,771,216 | — | $0 | 0 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 18,206,358 | — | $0 | 18,206,358 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 18,206,358 | — | $0 | 18,206,358 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 75,000 | — | $0 | 1,456,435 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 958 | — | $0 | 2,874 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 306 | — | $0 | 918 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-04-13 | 2021-04-15 | 75,000 | — | $0 | 1,456,437 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 282,219 | — | $0 | 15,051,678 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 217,781 | — | $0 | 11,614,985 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 1,019 | — | $0 | 4,068 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-08 | 2021-04-09 | 3,161 | — | $0 | 12,642 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 1,019 | — | $0 | 3,049 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 3,161 | — | $0 | 9,481 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 282,219 | — | $0 | 15,333,897 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-07 | 2021-04-09 | 217,781 | — | $0 | 11,832,766 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 217,781 | — | $0 | 12,050,547 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 282,219 | — | $0 | 15,616,116 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 3,160 | — | $0 | 6,320 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-04-01 | 2021-04-01 | 1,016 | — | $0 | 2,030 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 811 | — | $0 | 2,434 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 200,000 | — | $0 | 3,521,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 200,000 | — | $0 | 3,521,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 2,555 | — | $0 | 7,663 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 1,014 | — | $0 | 1,014 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 3,160 | — | $0 | 3,160 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 217,781 | — | $0 | 12,268,328 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2021-03-30 | 2021-04-01 | 282,219 | — | $0 | 15,898,335 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 2,555 | — | $0 | 5,108 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 200,000 | — | $0 | 3,721,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 200,000 | — | $0 | 3,721,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 813 | — | $0 | 1,623 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 2,553 | — | $0 | 2,553 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 810 | — | $0 | 810 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 200,000 | — | $0 | 3,921,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 200,000 | — | $0 | 3,921,520 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,303,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,301,250 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-01-08 | 2021-01-12 | 958 | — | $0 | 1,916 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-01-08 | 2021-01-12 | 75,000 | — | $0 | 1,531,437 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-01-08 | 2021-01-12 | 75,000 | — | $0 | 1,531,435 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2021-01-08 | 2021-01-12 | 306 | — | $0 | 612 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 2,927,386 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 669,977 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 665,661 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 180,578 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion deriv | 2020-12-22 | 2020-12-22 | 981,443 | — | $0 | 0 | SEC↗ |
| MASS 908 Devices Inc. | P Buy | 2020-12-22 | 2020-12-22 | 300,000 | $20.00 | $6.00M | 5,725,045 | SEC↗ |
| MASS 908 Devices Inc. | C Conversion | 2020-12-22 | 2020-12-22 | 5,425,045 | — | $0 | 5,425,045 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 1,036 | — | $0 | 1,889 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 1,034 | — | $0 | 1,888 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 176,920 | — | $0 | 1,214,770 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 277,514 | — | $0 | 1,905,481 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 854 | — | $0 | 854 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 145,994 | — | $0 | 1,391,690 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 229,006 | — | $0 | 2,182,995 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 853 | — | $0 | 853 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2020-11-12 | 2020-11-16 | 75,000 | — | $0 | 1,606,435 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2020-11-12 | 2020-11-16 | 958 | — | $0 | 958 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2020-11-12 | 2020-11-16 | 306 | — | $0 | 306 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2020-11-12 | 2020-11-16 | 75,000 | — | $0 | 1,606,437 | SEC↗ |
| PI IMPINJ INC | M Exercise deriv | 2020-10-23 | 2020-10-23 | 3,411 | — | $0 | 0 | SEC↗ |
| PI IMPINJ INC | M Exercise | 2020-10-23 | 2020-10-23 | 3,411 | — | $0 | 17,125 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 6,500,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 13,950,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 1,320,097 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,333,333 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 831,521 | — | $0 | 831,521 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 191,721 | — | $0 | 1,350,195 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2020-10-16 | 2020-10-20 | 235,000 | $15.00 | $3.52M | 2,503,903 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 1,784,572 | — | $0 | 1,848,535 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 326,953 | — | $0 | 1,158,474 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 420,368 | — | $0 | 2,268,903 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 472,251 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 2,571,769 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 210,000 | $13.00 | $2.73M | 2,781,769 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 20,000 | $13.00 | $260.0K | 158,734 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 138,734 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 472,251 | — | $0 | 2,433,035 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 1,960,784 | SEC↗ |
| PI IMPINJ INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,849 | — | $0 | 2,849 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 33,184 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 2,750,335 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 1,338,000 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 2,750,336 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 1,338,000 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 33,184 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-11 | 4,121,520 | — | $0 | 4,121,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-11 | 4,121,519 | — | $0 | 4,121,519 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-11-15 | 2019-11-19 | 410,820 | — | $0 | 0 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-11-15 | 2019-11-19 | 757 | — | $0 | 13,714 | SEC↗ |
| PI IMPINJ INC | A Award deriv | 2019-10-23 | 2019-10-24 | 3,411 | — | $0 | 3,411 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 2,222,222 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 11,111,110 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 13,333,332 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 555,555 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2019-10-16 | 2019-10-18 | 1,000,000 | $20.00 | $20.00M | 1,000,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 15,555,554 | — | $0 | 15,555,554 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 11,666,665 | — | $0 | 12,111,109 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-08-28 | 2019-08-30 | 331,781 | — | $0 | 410,820 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-08-28 | 2019-08-30 | 610 | — | $0 | 12,957 | SEC↗ |
| PI IMPINJ INC | M Exercise deriv | 2019-08-13 | 2019-08-15 | 4,754 | — | $0 | 0 | SEC↗ |
| PI IMPINJ INC | M Exercise | 2019-08-13 | 2019-08-15 | 4,754 | — | $0 | 12,347 | SEC↗ |
| DNI Denali Therapeutics Inc. | J Other | 2019-08-08 | 2019-08-12 | 400,000 | — | $0 | 10,668,749 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-07-31 | 2019-08-02 | 322,158 | — | $0 | 742,601 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-07-31 | 2019-08-02 | 596 | — | $0 | 7,593 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-07-17 | 2019-07-17 | 34,521 | $7.70 | $265.8K | 4,242,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-07-16 | 2019-07-17 | 25,779 | $7.81 | $201.3K | 4,276,572 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-07-15 | 2019-07-17 | 2,700 | $8.27 | $22.3K | 4,302,051 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion deriv | 2019-07-02 | 2019-07-02 | 557,207 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion deriv | 2019-07-02 | 2019-07-02 | 660,501 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion deriv | 2019-07-02 | 2019-07-02 | 557,206 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion deriv | 2019-07-02 | 2019-07-02 | 660,502 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2019-07-02 | 2019-07-02 | 100,000 | $16.00 | $1.60M | 100,000 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion | 2019-07-02 | 2019-07-02 | 723,643 | — | $0 | 823,643 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion | 2019-07-02 | 2019-07-02 | 723,644 | — | $0 | 823,644 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2019-07-02 | 2019-07-02 | 100,000 | $16.00 | $1.60M | 100,000 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion | 2019-07-02 | 2019-07-02 | 857,792 | — | $0 | 1,681,435 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion | 2019-07-02 | 2019-07-02 | 857,793 | — | $0 | 1,681,437 | SEC↗ |
| FIXX Homology Medicines, Inc. | J Other | 2019-05-21 | 2019-05-23 | 300,001 | — | $0 | 5,768,694 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-05-03 | 2019-05-07 | 557 | — | $0 | 6,997 | SEC↗ |
| PI IMPINJ INC | J Other | 2019-05-03 | 2019-05-07 | 301,976 | — | $0 | 1,064,759 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-14 | 2019-03-14 | 43,000 | $8.15 | $350.4K | 4,305,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-13 | 2019-03-14 | 2,820 | $8.20 | $23.1K | 4,348,051 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-13 | 2019-03-14 | 81,591 | $7.89 | $643.8K | 4,350,871 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-12 | 2019-03-14 | 40,092 | $7.37 | $295.5K | 4,432,462 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-11 | 2019-03-11 | 44,878 | $6.49 | $291.3K | 4,472,554 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-08 | 2019-03-11 | 84,496 | $6.93 | $585.6K | 4,517,432 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-03-07 | 2019-03-11 | 35,209 | $6.87 | $241.9K | 4,601,928 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 1,554,388 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 1,554,388 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 16,571,428 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 16,571,429 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 345,419 | — | $0 | 4,027,958 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 3,682,539 | — | $0 | 3,682,539 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 3,682,539 | — | $0 | 3,682,539 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 345,419 | — | $0 | 4,027,958 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 266,776 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 1,182,645 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 718,275 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 224,726 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 894,146 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 718,275 | — | $0 | 1,900,920 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 1,182,645 | — | $0 | 1,182,645 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 266,776 | — | $0 | 2,167,696 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 224,726 | — | $0 | 2,392,422 | SEC↗ |
| TWST Twist Bioscience Corp | P Buy | 2018-11-02 | 2018-11-06 | 15,000 | $14.00 | $210.0K | 2,407,422 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 894,146 | — | $0 | 894,146 | SEC↗ |
| TWST Twist Bioscience Corp | P Buy | 2018-11-02 | 2018-11-06 | 60,000 | $14.00 | $840.0K | 954,146 | SEC↗ |
| PI IMPINJ INC | A Award deriv | 2018-08-13 | 2018-08-16 | 4,754 | — | $0 | 4,754 | SEC↗ |